{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["33(1)"],"submitter":["Hong M"],"pubmed_abstract":["<h4>Objectives</h4>Early detection of developmental issues in infants and necessary intervention are important. To identify the comorbid conditions, a comprehensive evaluation is required. The study's objectives were to 1) generate scale items by identifying and eliciting concepts relevant to young children (12-71 months) with developmental delays, 2) develop a comprehensive screening tool for developmental delay and comorbid conditions, and 3) assess the tool's validity and cut-off.<h4>Methods</h4>Multidisciplinary experts devised the \"Infant Comprehensive Evaluation for Neurodevelopmental Delay (ICEND),\" an assessment method that comes in two versions depending on the age of the child: 12-36 months and 37-71 months, through monthly seminars and focused group interviews. The ICEND is comp"],"journal":["Soa--ch'ongsonyon chongsin uihak = Journal of child & adolescent psychiatry"],"pagination":["16-23"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC8733413"],"repository":["biostudies-literature"],"pubmed_title":["Preliminary Report of Validity for the Infant Comprehensive Evaluation for Neurodevelopmental Delay, a Newly Developed Inventory for Children Aged 12 to 71 Months."],"pmcid":["PMC8733413"],"pubmed_authors":["Hong M","Bahn GH","Lee KS","Shin YW","Lee SY","Kang JY","Moon DS","Cho YI","Cho S","Hwangbo R","Park JA"],"additional_accession":[]},"is_claimable":false,"name":"Preliminary Report of Validity for the Infant Comprehensive Evaluation for Neurodevelopmental Delay, a Newly Developed Inventory for Children Aged 12 to 71 Months.","description":"<h4>Objectives</h4>Early detection of developmental issues in infants and necessary intervention are important. To identify the comorbid conditions, a comprehensive evaluation is required. The study's objectives were to 1) generate scale items by identifying and eliciting concepts relevant to young children (12-71 months) with developmental delays, 2) develop a comprehensive screening tool for developmental delay and comorbid conditions, and 3) assess the tool's validity and cut-off.<h4>Methods</h4>Multidisciplinary experts devised the \"Infant Comprehensive Evaluation for Neurodevelopmental Delay (ICEND),\" an assessment method that comes in two versions depending on the age of the child: 12-36 months and 37-71 months, through monthly seminars and focused group interviews. The ICEND is comp","dates":{"release":"2022-01-01T00:00:00Z","publication":"2022 Jan","modification":"2025-04-04T20:31:55.335Z","creation":"2022-02-11T15:20:30.483Z"},"accession":"S-EPMC8733413","cross_references":{"pubmed":["35035238"],"doi":["10.5765/jkacap.210033"]}}